Literature DB >> 18337553

History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.

Steven M Brunelli1, Marshall M Joffe, Rubeen K Israni, Wei Yang, Steven Fishbane, Jeffrey S Berns, Harold I Feldman.   

Abstract

BACKGROUND AND OBJECTIVES: Hemoglobin variability is common among dialysis patients, and has been associated with increased mortality. The causal nature of this association has been difficult to ascertain because of potential time-dependent confounding, for which traditional statistical methods do not control. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: A retrospective cohort of 34,963 Fresenius Medical care dialysis patients from 1996 was assembled. Hemoglobin variability, absolute hemoglobin level, and temporal hemoglobin trend were measured over rolling 6-mo exposure windows. Their association with mortality was estimated using history-adjusted marginal structural analysis that adjusts for time-dependent confounding by applying weights to observations inversely related to the predictability of observed levels of hemoglobin.
RESULTS: In the primary analysis, each g/dl increase in hemoglobin variability was associated with an adjusted hazard ratio (HR) [95% confidence interval (CI)] for all-cause mortality of 1.93 (1.20 to 3.10). Neither higher absolute hemoglobin level nor increasing hemoglobin trend were significantly associated with mortality; adjusted HR (95% CI) 0.85 (0.64 to 1.11) and 0.60 (0.25 to 1.45), respectively.
CONCLUSIONS: Marginal structural analysis demonstrates that hemoglobin variability is associated with increased mortality among chronic hemodialysis patients, and that this effect is more pronounced than appreciated using standard statistical techniques that do not take time-dependent confounding into account.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337553      PMCID: PMC2386696          DOI: 10.2215/CJN.04281007

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  Causal inference in longitudinal studies with history-restricted marginal structural models.

Authors:  Romain Neugebauer; Mark J van der Laan; Marshall M Joffe; Ira B Tager
Journal:  Electron J Stat       Date:  2007-01-01       Impact factor: 1.125

2.  Compensatory and adaptive changes in microcirculation and left ventricular function of patients with chronic iron-deficiency anaemia.

Authors:  Z Georgieva; M Georgieva
Journal:  Clin Hemorheol Microcirc       Date:  1997 Jan-Feb       Impact factor: 2.375

3.  A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods.

Authors:  J Robins
Journal:  J Chronic Dis       Date:  1987

4.  Disturbances of the heart structure and function in chronic hemolytic anemia, their compensation with increased coronary flow, and their prevention with ionol, an inhibitor of lipid peroxidation.

Authors:  F Z Meerson; M E Evsevieva
Journal:  Adv Myocardiol       Date:  1985

5.  Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Authors:  Nancy R Cook; Stephen R Cole; Charles H Hennekens
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

Review 6.  The physiology of oxygen transport.

Authors:  O P Habler; K F Messmer
Journal:  Transfus Sci       Date:  1997-09

7.  Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.

Authors:  Steven Fishbane; Jeffrey S Berns
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.

Authors:  Eric D Weinhandl; Madhumati Rao; David T Gilbertson; Allan J Collins; Brian J G Pereira
Journal:  Am J Kidney Dis       Date:  2007-11       Impact factor: 8.860

9.  Hemoglobin variability in epoetin-treated hemodialysis patients.

Authors:  Jeffrey S Berns; Hafez Elzein; Robert I Lynn; Steven Fishbane; Ira S Meisels; Peter B Deoreo
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

10.  Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations.

Authors:  James P Ebben; David T Gilbertson; Robert N Foley; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-06       Impact factor: 8.237

View more
  29 in total

1.  Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients.

Authors:  Alexander Kainz; Bernd Mayer; Reinhard Kramar; Rainer Oberbauer
Journal:  Nephrol Dial Transplant       Date:  2010-05-26       Impact factor: 5.992

2.  The relation between hemoglobin variability and carotid intima-media thickness in chronic hemodialysis patients.

Authors:  Safa Ersen Ganidagli; Orcun Altunoren; Ertuğrul Erken; Ismet Onder Isık; Berivan Ganidagli; Necmi Eren; Yasemin Coskun Yavuz; Ozkan Gungor
Journal:  Int Urol Nephrol       Date:  2017-07-15       Impact factor: 2.370

3.  Determining optimum hemoglobin sampling for anemia management from every-treatment data.

Authors:  Adam E Gaweda; Brian H Nathanson; Alfred A Jacobs; George R Aronoff; Michael J Germain; Michael E Brier
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

4.  Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.

Authors:  Keiichi Sumida; Charles Dyer Diskin; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Connie M Rhee; Elani Streja; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Am J Nephrol       Date:  2017-11-07       Impact factor: 3.754

5.  Relationship between epoetin alfa dose and mortality: findings from a marginal structural model.

Authors:  Ouhong Wang; Ryan D Kilpatrick; Cathy W Critchlow; Xiang Ling; Brian D Bradbury; David T Gilbertson; Allan J Collins; Kenneth J Rothman; John F Acquavella
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

6.  Exploration of lagged associations using longitudinal data.

Authors:  Patrick J Heagerty; Bryan A Comstock
Journal:  Biometrics       Date:  2013-01-22       Impact factor: 2.571

7.  Route of epoetin administration influences hemoglobin variability in hemodialysis patients.

Authors:  Tejas Patel; Angie Hirter; James Kaufman; Sai Ram Keithi-Reddy; Domenic Reda; Ajay Singh
Journal:  Am J Nephrol       Date:  2008-10-21       Impact factor: 3.754

8.  Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.

Authors:  Steven M Brunelli; Glenn M Chertow; Elizabeth D Ankers; Edmund G Lowrie; Ravi Thadhani
Journal:  Kidney Int       Date:  2010-01-20       Impact factor: 10.612

9.  Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.

Authors:  Angel L M de Francisco; Peter Stenvinkel; Sophie Vaulont
Journal:  NDT Plus       Date:  2009-01

10.  Maintaining over time clinical performance targets on anaemia correction in unselected population on chronic dialysis at 20 Italian centres. Data from a retrospective study for a clinical audit.

Authors:  Silvia Soffritti; Giorgia Russo; Stefano Cantelli; Giuseppe Gilli; Luigi Catizone
Journal:  BMC Nephrol       Date:  2009-10-24       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.